TNT-NPP-001

N/A

Report date: 2025/01/26 16:21:30
NME

Base Information

Drug NameTNT-NPP-001
Drug Alias Nametriple DAT/NET/SERT inhibitor 5 (Trineurotec)TNT-NPP-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsNorepinephrine transporter inhibitorsSerotonin transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrineurotec
China Registration ClassN/A

Develop Information

Active CompaniesTrineurotec
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A